Delivery Order SPE2DR25D2104-SPE2DR26F3NCA
- Not listed
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a $2,469.78 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by December 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,348.90 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on November 14, 2025, with completion expected by December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract supports the procurement of this specialized pharmaceutical product for federal...
- The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on October 29, 2025, with a completion date of November 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $28,123.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger procurement vehicle...
- The Defense Logistics Agency awarded a $7,030.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $12,348.90 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml syringes on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes valued at $2,343.59, with an ultimate completion date of October 1, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $9,374.36 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a non-competitive set-aside contract. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NCADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on November 3, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains. The Tezspire delivery order fulfills critical pharmaceutical support requirements for the Defense Health Agency and other federal healthcare systems within the broader framework of this comprehensive pharmaceutical supply agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 11/3/25 |